Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 5.0 | 2.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 1.4 | 1.86 |
NAV | ₹165.83 | ₹25.49 |
Fund Started | 26 Aug 2010 | 02 Dec 2020 |
Fund Size | ₹68571.85 Cr | ₹4833.23 Cr |
Exit Load | Exit load of 1% if redeemed within 1 year. | Exit load of 1% if redeemed within one year. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | -8.81% | -7.13% |
3 Year | 20.09% | 16.82% |
5 Year | 27.89% | - |
1 Year
3 Year
5 Year
Equity | 95.85% | 94.80% |
Cash | 4.15% | 5.17% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Multi Commodity Exchange Of India Ltd. | 2.72% |
HDFC Bank Ltd. | 1.95% |
State Bank of India | 1.48% |
Karur Vysya Bank Ltd. | 1.38% |
Bharat Heavy Electricals Ltd. | 1.25% |
Apar Industries Ltd. | 1.20% |
TD Power Systems Ltd. | 1.16% |
eClerx Services Ltd. | 1.14% |
Reliance Industries Ltd. | 1.13% |
Axis Bank Ltd. | 1.12% |
Name | Assets |
|---|---|
City Union Bank Ltd. | 2.59% |
Karur Vysya Bank Ltd. | 2.55% |
Multi Commodity Exchange Of India Ltd. | 2.34% |
Aster DM Healthcare Ltd. | 2.23% |
TD Power Systems Ltd. | 2.09% |
Acutaas Chemicals Ltd. | 1.99% |
Kei Industries Ltd. | 1.95% |
Navin Fluorine International Ltd. | 1.86% |
Affle 3I Ltd. | 1.80% |
Eris Lifesciences Ltd. | 1.77% |
Name | Akshay Sharma | Nitin Jain |
Start Date | 01 Dec 2022 | 01 Oct 2024 |
Name
Start Date
Description | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related instruments of small cap companies. | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of small cap companies. |
Launch Date | 26 Aug 2010 | 02 Dec 2020 |
Description
Launch Date